PACS Group's (PACS) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.

PACS Group (NYSE:PACS - Get Free Report)'s stock had its "neutral" rating reaffirmed by analysts at JPMorgan Chase & Co. in a report released on Tuesday, MarketBeat Ratings reports. They presently have a $18.00 target price on the stock. JPMorgan Chase & Co.'s price target points to a potential upside of 29.03% from the stock's previous close.

Several other equities research analysts also recently weighed in on the stock. Citigroup initiated coverage on shares of PACS Group in a research note on Wednesday, September 11th. They issued a "buy" rating and a $45.00 target price on the stock. Truist Financial lifted their price objective on shares of PACS Group from $44.00 to $46.00 and gave the company a "buy" rating in a research note on Monday, October 14th. UBS Group assumed coverage on shares of PACS Group in a research note on Wednesday, October 9th. They set a "buy" rating and a $50.00 target price on the stock. Finally, Stephens lowered their price target on shares of PACS Group from $48.00 to $31.00 and set an "overweight" rating on the stock in a research report on Monday, November 18th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $37.13.

PACS Group Stock Performance

Shares of NYSE PACS traded down $1.23 during midday trading on Tuesday, hitting $13.95. The stock had a trading volume of 1,046,715 shares, compared to its average volume of 900,305. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.82. The business's 50 day moving average is $26.68 and its 200-day moving average is $32.02. PACS Group has a 52 week low of $13.80 and a 52 week high of $43.92.

Institutional Trading of PACS Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp bought a new stake in shares of PACS Group during the second quarter worth approximately $2,445,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of PACS Group during the 2nd quarter worth about $7,513,000. Rhumbline Advisers bought a new position in PACS Group in the 2nd quarter valued at about $870,000. Oppenheimer Asset Management Inc. bought a new position in PACS Group in the 2nd quarter valued at about $552,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of PACS Group in the 2nd quarter valued at approximately $1,195,000.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.